Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.

MLA

Dawson, D. M., et al. “Immunosuppression in Progressive Multiple Sclerosis with High Dose Intravenous Cyclophosphamide and Monoclonal Antibodies.” Rivista Di Neurologia, vol. 57, no. 2, Mar. 1987, pp. 88–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3039645&authtype=sso&custid=ns315887.

APA

Dawson, D. M., Carter, J. L., Hafler, D. A., & Weiner, H. L. (1987). Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Rivista Di Neurologia, 57(2), 88–91.

Chicago

Dawson, D M, J L Carter, D A Hafler, and H L Weiner. 1987. “Immunosuppression in Progressive Multiple Sclerosis with High Dose Intravenous Cyclophosphamide and Monoclonal Antibodies.” Rivista Di Neurologia 57 (2): 88–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3039645&authtype=sso&custid=ns315887.